Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Protein activation mapping of human sun-protected epidermis after an acute dose of erythemic solar simulated light.

Einspahr JG, Curiel-Lewandrowski C, Calvert VS, Stratton SP, Alberts DS, Warneke J, Hu C, Saboda K, Wagener EL, Dickinson S, Dong Z, Bode AM, PetricoinIII EF.

NPJ Precis Oncol. 2017;1. pii: 34. doi: 10.1038/s41698-017-0037-7. Epub 2017 Sep 21.

2.

High Proportion of Nuclear Phenotype Identifies Aggressive Cutaneous Squamous Cell Carcinoma.

Glazer ES, Bartels PH, Liang J, Prasad AR, Yozwiak ML, Krutzsch M, Clark C, Kha S, Bartels HG, Einspahr JG, Alberts DS, Krouse RS.

Anal Quant Cytopathol Histpathol. 2015 Oct;37(5):302-9.

PMID:
26856115
3.

Phase IIB Randomized Study of Topical Difluoromethylornithine and Topical Diclofenac on Sun-Damaged Skin of the Forearm.

Jeter JM, Curiel-Lewandrowski C, Stratton SP, Myrdal PB, Warneke JA, Einspahr JG, Bartels HG, Yozwiak M, Bermudez Y, Hu C, Bartels P, Alberts DS.

Cancer Prev Res (Phila). 2016 Feb;9(2):128-34. doi: 10.1158/1940-6207.CAPR-15-0232. Epub 2015 Dec 28.

4.

Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin.

Bermudez Y, Stratton SP, Curiel-Lewandrowski C, Warneke J, Hu C, Bowden GT, Dickinson SE, Dong Z, Bode AM, Saboda K, Brooks CA, Petricoin EF 3rd, Hurst CA, Alberts DS, Einspahr JG.

Cancer Prev Res (Phila). 2015 Aug;8(8):720-8. doi: 10.1158/1940-6207.CAPR-14-0407. Epub 2015 Jun 1.

5.

Pilot study on the bioactivity of vitamin d in the skin after oral supplementation.

Curiel-Lewandrowski C, Tang JY, Einspahr JG, Bermudez Y, Hsu CH, Rezaee M, Lee AH, Tangrea J, Parnes HL, Alberts DS, Chow HH.

Cancer Prev Res (Phila). 2015 Jun;8(6):563-9. doi: 10.1158/1940-6207.CAPR-14-0280. Epub 2015 Apr 2.

6.

Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity.

Curiel-Lewandrowski C, Swetter SM, Einspahr JG, Hsu CH, Nagle R, Sagerman P, Tangrea J, Parnes H, Alberts DS, Chow HH.

Cancer. 2012 Dec 1;118(23):5848-56. doi: 10.1002/cncr.27540. Epub 2012 May 17.

7.

Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma.

Einspahr JG, Calvert V, Alberts DS, Curiel-Lewandrowski C, Warneke J, Krouse R, Stratton SP, Liotta L, Longo C, Pellacani G, Prasad A, Sagerman P, Bermudez Y, Deng J, Bowden GT, Petricoin EF 3rd.

Cancer Prev Res (Phila). 2012 Mar;5(3):403-13. doi: 10.1158/1940-6207.CAPR-11-0427. Erratum in: Cancer Prev Res (Phila). 2012 Aug;5(8):1072. Pellicani, Giovanni [corrected to Pellacani, Giovanni].

8.

Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma.

Glazer ES, Bartels PH, Prasad AR, Yozwiak ML, Bartels HG, Einspahr JG, Alberts DS, Krouse RS.

Cancer Prev Res (Phila). 2011 Nov;4(11):1770-7. doi: 10.1158/1940-6207.CAPR-10-0404. Epub 2011 Jun 2.

9.

Loss of inositol polyphosphate 5-phosphatase is an early event in development of cutaneous squamous cell carcinoma.

Sekulic A, Kim SY, Hostetter G, Savage S, Einspahr JG, Prasad A, Sagerman P, Curiel-Lewandrowski C, Krouse R, Bowden GT, Warneke J, Alberts DS, Pittelkow MR, DiCaudo D, Nickoloff BJ, Trent JM, Bittner M.

Cancer Prev Res (Phila). 2010 Oct;3(10):1277-83. doi: 10.1158/1940-6207.CAPR-10-0058. Epub 2010 Sep 28.

10.

A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer.

Stratton SP, Alberts DS, Einspahr JG, Sagerman PM, Warneke JA, Curiel-Lewandrowski C, Myrdal PB, Karlage KL, Nickoloff BJ, Brooks C, Saboda K, Yozwiak ML, Krutzsch MF, Hu C, Lluria-Prevatt M, Dong Z, Bowden GT, Bartels PH.

Cancer Prev Res (Phila). 2010 Feb;3(2):160-9. doi: 10.1158/1940-6207.CAPR-09-0183. Epub 2010 Jan 26.

11.

Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol.

Foote JA, Ranger-Moore JR, Einspahr JG, Saboda K, Kenyon J, Warneke J, Miller RC, Goldman R, Xu MJ, Roe DJ, Alberts DS.

Cancer Prev Res (Phila). 2009 Apr;2(4):394-400. doi: 10.1158/1940-6207.CAPR-08-0210. Epub 2009 Mar 31.

12.

Phase 1 study of topical perillyl alcohol cream for chemoprevention of skin cancer.

Stratton SP, Saboda KL, Myrdal PB, Gupta A, McKenzie NE, Brooks C, Salasche SJ, Warneke JA, Ranger-Moore J, Bozzo PD, Blanchard J, Einspahr JG, Dorr RT, Levine N, Alberts DS.

Nutr Cancer. 2008;60(3):325-30. doi: 10.1080/01635580701840391.

PMID:
18444166
13.

Cross-validation of murine UV signal transduction pathways in human skin.

Einspahr JG, Bowden GT, Alberts DS, McKenzie N, Saboda K, Warneke J, Salasche S, Ranger-Moore J, Curiel-Lewandrowski C, Nagle RB, Nickoloff BJ, Brooks C, Dong Z, Stratton SP.

Photochem Photobiol. 2008 Mar-Apr;84(2):463-76. doi: 10.1111/j.1751-1097.2007.00287.x. Epub 2008 Jan 29.

PMID:
18248498
14.

Karyometry of the colonic mucosa.

Alberts DS, Einspahr JG, Krouse RS, Prasad A, Ranger-Moore J, Hamilton P, Ismail A, Lance P, Goldschmid S, Hess LM, Yozwiak M, Bartels HG, Bartels PH.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2704-16.

15.

Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.

Einspahr JG, Thomas TL, Saboda K, Nickolof BJ, Warneke J, Curiel-Lewandrowski C, Ranger-Moore J, Duckett L, Bangert J, Fruehauf JP, Alberts DS.

Cancer. 2007 Dec 1;110(11):2519-27.

16.

Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.

Einspahr JG, Xu MJ, Warneke J, Saboda K, Ranger-Moore J, Bozzo P, Duckett L, Goldman R, Lin P, Buckmeier J, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1841-8. Epub 2006 Oct 4.

17.

Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

Einspahr JG, Martinez ME, Jiang R, Hsu CH, Rashid A, Bhattacharrya AK, Ahnen DJ, Jacobs ET, Houlihan PS, Webb CR, Alberts DS, Hamilton SR.

Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1443-50. Erratum in: Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):2016. Rashid, Asif [added].

18.

MGMT promoter methylation and field defect in sporadic colorectal cancer.

Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP.

J Natl Cancer Inst. 2005 Sep 21;97(18):1330-8.

PMID:
16174854
19.

Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.

Alberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P; Phoenix and Tucson Gastroenterologist Networks.

J Natl Cancer Inst. 2005 Jun 1;97(11):846-53.

PMID:
15928305
20.

Reliability and validity of a histologic score as a marker for skin cancer chemoprevention studies.

Bozzo P, Saboda K, Einspahr JG, Ranger-Moore J, Farmer ER, Cockerell CJ, Elder DE, Bangert JL, Hart N, Kramer CB, Alberts DS.

Anal Quant Cytol Histol. 2003 Oct;25(5):285-92.

PMID:
14603727
21.

Skin cancer chemoprevention: strategies to save our skin.

Einspahr JG, Bowden GT, Alberts DS.

Recent Results Cancer Res. 2003;163:151-64; discussion 264-6. Review.

PMID:
12903851
22.

Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival.

Raffel J, Bhattacharyya AK, Gallegos A, Cui H, Einspahr JG, Alberts DS, Powis G.

J Lab Clin Med. 2003 Jul;142(1):46-51.

PMID:
12878985
23.

Association between Cyclooxygenase expression and colorectal adenoma characteristics.

Einspahr JG, Krouse RS, Yochim JM, Danenberg PV, Danenberg KD, Bhattacharyya AK, Martínez ME, Alberts DS.

Cancer Res. 2003 Jul 15;63(14):3891-3.

24.

Fecal bile acid concentrations in a subpopulation of the wheat bran fiber colon polyp trial.

Alberts DS, Einspahr JG, Earnest DL, Krutzsch MF, Lin P, Hess LM, Heddens DK, Roe DJ, Martínez ME, Salen G, Batta AK.

Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):197-200.

25.

Chemoprevention of human skin cancer.

Einspahr JG, Stratton SP, Bowden GT, Alberts DS.

Crit Rev Oncol Hematol. 2002 Mar;41(3):269-85. Review.

PMID:
11880204
26.

Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer.

Einspahr JG, Nelson MA, Saboda K, Warneke J, Bowden GT, Alberts DS.

Clin Cancer Res. 2002 Jan;8(1):149-55.

27.

Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial.

Calaluce R, Earnest DL, Heddens D, Einspahr JG, Roe D, Bogert CL, Marshall JR, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1287-92.

28.

Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine.

Alberts DS, Dorr RT, Einspahr JG, Aickin M, Saboda K, Xu MJ, Peng YM, Goldman R, Foote JA, Warneke JA, Salasche S, Roe DJ, Bowden GT.

Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1281-6.

29.

Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis.

Einspahr JG, Alberts DS, Warneke JA, Bozzo P, Basye J, Grogan TM, Nelson MA, Bowden GT.

Neoplasia. 1999 Nov;1(5):468-75.

30.

Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E2 levels in healthy subjects with a history of resected polyps.

Chow HH, Earnest DL, Clark D, Mason-Liddil N, Kramer CB, Einspahr JG, Guillen-Rodriguez JM, Roe DJ, Malone W, Crowell JA, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 2000 Apr;9(4):351-6.

31.

Protective role of wheat bran fiber: data from marker trials.

Earnest DL, Einspahr JG, Alberts DS.

Am J Med. 1999 Jan 25;106(1A):32S-37S. Review.

PMID:
10089113
32.

Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials.

Einspahr JG, Alberts DS, Gapstur SM, Bostick RM, Emerson SS, Gerner EW.

Cancer Epidemiol Biomarkers Prev. 1997 Jan;6(1):37-48. Review.

33.

Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers.

Nelson MA, Einspahr JG, Alberts DS, Balfour CA, Wymer JA, Welch KL, Salasche SJ, Bangert JL, Grogan TM, Bozzo PO.

Cancer Lett. 1994 Sep 30;85(1):23-9.

PMID:
7923098
34.

Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide).

Alberts DS, Einspahr JG, Struck R, Bignami G, Young L, Surwit EA, Salmon SE.

Invest New Drugs. 1984;2(2):141-8.

PMID:
6469507
35.

Pharmacokinetics of 13-cis-retinoic acid in patients with advanced cancer.

Goodman GE, Einspahr JG, Alberts DS, Davis TP, Leigh SA, Chen HS, Meyskens FL.

Cancer Res. 1982 May;42(5):2087-91.

Supplemental Content

Loading ...
Support Center